APO RESEARCH · REPORT
GMP Cytokines
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
Product & engineering
Understand the product.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Selected research
Market Structure
Global GMP Cytokines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Global key players of GMP Cytokines include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva and Lonza, etc. Top three players occupy for a share about 46%. North America is the largest market, with a share about 54%, followed by Europe and Asia-Pacific. In terms of product, Growth Factor is the largest segment, with a share over 55%. In terms of application, Cell/Gene Therapy is the largest market, with a share over 54%.
Read the full market overview
This report provides an overview of the global GMP Cytokines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP Cytokines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP Cytokines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GMP Cytokines market size, projected growth trends, production technologies, key applications, and end-use industries.
GMP Cytokines Segment by Company
Miltenyi Biotec
Bio-Techne
Cytiva
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog
GMP Cytokines Segment by Type
TNF
Interleukin
Growth Factor
Others
GMP Cytokines Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
GMP Cytokines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cytokines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cytokines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cytokines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the GMP Cytokines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GMP Cytokines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of GMP Cytokines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- TNF
- Interleukin
- Growth Factor
- Others
Applications
- Cell/Gene Therapy
- Tissue-Engineered Products
- Others
Companies covered
- Miltenyi Biotec
- Bio-Techne
- Cytiva
- Lonza
- CellGenix
- ReproCELL
- PeproTech
- Sino Biological
- Creative Bioarray
- Akron Biotech
- Almog
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global GMP Cytokines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global GMP Cytokines Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global GMP Cytokines Sales Estimates and Forecasts (2021-2032)
- 1.5 Global GMP Cytokines Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global GMP Cytokines Market Dynamics
- 2.1 GMP Cytokines Industry Trends
- 2.2 GMP Cytokines Industry Drivers
- 2.3 GMP Cytokines Industry Opportunities and Challenges
- 2.4 GMP Cytokines Industry Restraints
3 GMP Cytokines Market by Manufacturers
- 3.1 Global GMP Cytokines Revenue by Manufacturers (2021-2026)
- 3.2 Global GMP Cytokines Sales by Manufacturers (2021-2026)
- 3.3 Global GMP Cytokines Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global GMP Cytokines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GMP Cytokines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global GMP Cytokines Manufacturers, Product Type & Application
- 3.7 Global GMP Cytokines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global GMP Cytokines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 GMP Cytokines Players Market Share by Revenue in 2025
- 3.8.3 2025 GMP Cytokines Tier 1, Tier 2, and Tier 3
4 GMP Cytokines Market by Type
- 4.1 GMP Cytokines Type Introduction
- 4.1.1 TNF
- 4.1.2 Interleukin
- 4.1.3 Growth Factor
- 4.1.4 Others
- 4.2 Global GMP Cytokines Sales by Type
- 4.2.1 Global GMP Cytokines Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global GMP Cytokines Sales by Type (2021-2032)
- 4.2.3 Global GMP Cytokines Sales Market Share by Type (2021-2032)
- 4.3 Global GMP Cytokines Revenue by Type
- 4.3.1 Global GMP Cytokines Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global GMP Cytokines Revenue by Type (2021-2032)
- 4.3.3 Global GMP Cytokines Revenue Market Share by Type (2021-2032)
5 GMP Cytokines Market by Application
- 5.1 GMP Cytokines Application Introduction
- 5.1.1 Cell/Gene Therapy
- 5.1.2 Tissue-Engineered Products
- 5.1.3 Others
- 5.2 Global GMP Cytokines Sales by Application
- 5.2.1 Global GMP Cytokines Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global GMP Cytokines Sales by Application (2021-2032)
- 5.2.3 Global GMP Cytokines Sales Market Share by Application (2021-2032)
- 5.3 Global GMP Cytokines Revenue by Application
- 5.3.1 Global GMP Cytokines Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global GMP Cytokines Revenue by Application (2021-2032)
- 5.3.3 Global GMP Cytokines Revenue Market Share by Application (2021-2032)
6 Global GMP Cytokines Sales by Region
- 6.1 Global GMP Cytokines Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global GMP Cytokines Sales by Region (2021-2032)
- 6.2.1 Global GMP Cytokines Sales by Region (2021-2026)
- 6.2.2 Global GMP Cytokines Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GMP Cytokines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America GMP Cytokines Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe GMP Cytokines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe GMP Cytokines Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific GMP Cytokines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific GMP Cytokines Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa GMP Cytokines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa GMP Cytokines Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global GMP Cytokines Revenue by Region
- 7.1 Global GMP Cytokines Revenue by Region
- 7.1.1 Global GMP Cytokines Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global GMP Cytokines Revenue by Region (2021-2026)
- 7.1.3 Global GMP Cytokines Revenue by Region (2027-2032)
- 7.1.4 Global GMP Cytokines Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America GMP Cytokines Revenue (2021-2032)
- 7.2.2 North America GMP Cytokines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe GMP Cytokines Revenue (2021-2032)
- 7.3.2 Europe GMP Cytokines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific GMP Cytokines Revenue (2021-2032)
- 7.4.2 Asia-Pacific GMP Cytokines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa GMP Cytokines Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa GMP Cytokines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Miltenyi Biotec
- 8.1.1 Miltenyi Biotec Company Information
- 8.1.2 Miltenyi Biotec Business Overview
- 8.1.3 Miltenyi Biotec GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Miltenyi Biotec GMP Cytokines Product Portfolio
- 8.1.5 Miltenyi Biotec Recent Developments
- 8.2 Bio-Techne
- 8.2.1 Bio-Techne Company Information
- 8.2.2 Bio-Techne Business Overview
- 8.2.3 Bio-Techne GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bio-Techne GMP Cytokines Product Portfolio
- 8.2.5 Bio-Techne Recent Developments
- 8.3 Cytiva
- 8.3.1 Cytiva Company Information
- 8.3.2 Cytiva Business Overview
- 8.3.3 Cytiva GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cytiva GMP Cytokines Product Portfolio
- 8.3.5 Cytiva Recent Developments
- 8.4 Lonza
- 8.4.1 Lonza Company Information
- 8.4.2 Lonza Business Overview
- 8.4.3 Lonza GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lonza GMP Cytokines Product Portfolio
- 8.4.5 Lonza Recent Developments
- 8.5 CellGenix
- 8.5.1 CellGenix Company Information
- 8.5.2 CellGenix Business Overview
- 8.5.3 CellGenix GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 CellGenix GMP Cytokines Product Portfolio
- 8.5.5 CellGenix Recent Developments
- 8.6 ReproCELL
- 8.6.1 ReproCELL Company Information
- 8.6.2 ReproCELL Business Overview
- 8.6.3 ReproCELL GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 ReproCELL GMP Cytokines Product Portfolio
- 8.6.5 ReproCELL Recent Developments
- 8.7 PeproTech
- 8.7.1 PeproTech Company Information
- 8.7.2 PeproTech Business Overview
- 8.7.3 PeproTech GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 PeproTech GMP Cytokines Product Portfolio
- 8.7.5 PeproTech Recent Developments
- 8.8 Sino Biological
- 8.8.1 Sino Biological Company Information
- 8.8.2 Sino Biological Business Overview
- 8.8.3 Sino Biological GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sino Biological GMP Cytokines Product Portfolio
- 8.8.5 Sino Biological Recent Developments
- 8.9 Creative Bioarray
- 8.9.1 Creative Bioarray Company Information
- 8.9.2 Creative Bioarray Business Overview
- 8.9.3 Creative Bioarray GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Creative Bioarray GMP Cytokines Product Portfolio
- 8.9.5 Creative Bioarray Recent Developments
- 8.10 Akron Biotech
- 8.10.1 Akron Biotech Company Information
- 8.10.2 Akron Biotech Business Overview
- 8.10.3 Akron Biotech GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Akron Biotech GMP Cytokines Product Portfolio
- 8.10.5 Akron Biotech Recent Developments
- 8.11 Almog
- 8.11.1 Almog Company Information
- 8.11.2 Almog Business Overview
- 8.11.3 Almog GMP Cytokines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Almog GMP Cytokines Product Portfolio
- 8.11.5 Almog Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 GMP Cytokines Value Chain Analysis
- 9.1.1 GMP Cytokines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 GMP Cytokines Production Mode & Process
- 9.2 GMP Cytokines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 GMP Cytokines Distributors
- 9.2.3 GMP Cytokines Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst